United States · Series B startup

Who invested in Halda Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$126Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $126MAug 2024
Investors
3
See who backed them

The rounds

  1. Aug 2024
    Series B$126M

    Source recordedSEC filing: $126M sold, first sale Jul 2024

Founders and team

From Halda Therapeutics's own website: 3 on the team.

  • Elizabeth ForminardExecutive Vice President, Chief Legal Officer
  • Joaquin DuatoChairman and Chief Executive Officer
  • Vanessa BroadhurstExecutive Vice President, Global Corporate Affairs

Everyone who backed them

CanaanVC firm1round
RA Capital ManagementPrivate equity1round
Connecticut InnovationsGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Halda Therapeutics

Who invested in Halda Therapeutics?

Halda Therapeutics's investors include Canaan, RA Capital Management and Connecticut Innovations.

How much has Halda Therapeutics raised?

Halda Therapeutics has raised $126M across 1 round since 2024.

When did Halda Therapeutics last raise?

Halda Therapeutics's most recent round was a Series B of $126M in Aug 2024.

What was Halda Therapeutics's biggest round?

Its most recent round, $126M in Aug 2024, is also its largest on record.

Who backed Halda Therapeutics first?

Halda Therapeutics's first round on record, in Aug 2024, was backed by Canaan, RA Capital Management and Connecticut Innovations.

What stage is Halda Therapeutics at?

Halda Therapeutics's latest named round is a Series B, in Aug 2024.

Where is Halda Therapeutics based?

Halda Therapeutics is based in the United States.

Companies like Halda Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.